HomeSLXN • NASDAQ
add
Silexion Therapeutics Corp
Previous close
$0.95
Day range
$0.91 - $0.97
Year range
$0.57 - $122.02
Market cap
8.00M USD
Avg Volume
2.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.24M | 204.45% |
Net income | -31.14M | -281.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -23.24M | -204.61% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.19M | -74.17% |
Total assets | 2.86M | -45.53% |
Total liabilities | 6.85M | 203.86% |
Total equity | -3.99M | — |
Shares outstanding | 8.41M | — |
Price to book | -0.44 | — |
Return on assets | -1,953.11% | — |
Return on capital | 3,020.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -31.14M | -281.79% |
Cash from operations | -2.93M | -132.78% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 2.18M | — |
Net change in cash | -753.00K | 35.48% |
Free cash flow | -15.54M | — |
About
Founded
2008
Website
Employees
13
